Avandia

Dangerous Drugs:

Avandia

Bookmark

RSS

Adjust font size:

Avandia Linked to Increased Risk of Heart Attack and Death

Avandia, a widely prescribed drug to treat type 2 diabetes, has been shown to increase users' risk of heart attack by 43 percent and cardiac-related death by 64 percent, according to researchers.

Because of the public health importance of this study, the New England Journal of Medicine released an early online version of an article that will appear in its June 14 issue.

More than 6 million people worldwide have used Avandia (generic name rosiglitazone) since it was approved 8 years ago to help control blood sugar in people with type 2 diabetes, the most common form of diabetes Currently, about 1 million Americans use Avandia.

The recent study was conducted by two doctors at the Cleveland Clinic who evaluated 42 studies that compared patients taking Avandia with those who were not. The overall study involved 28,000 patients, 15,560 of whom were taking Avandia.

Of those patients taking Avandia, 86 suffered heart attacks compared to 72 among patients not on the drug. In addition, another 39 patients died from cardiovascular causes compared to 22 patients who were not taking Avandia.

The Food and Drug Administration issued a safety alert on May 21, 2007 and will likely convene an advisory panel to look into the safety of Avandia.

Avandia is manufactured by GlaxoSmithKline, PLC.

If you or someone you know has taken Avandia and has suffered any serious side effects, please fill out this form or call us at 1-800-275-0192 for an immediate response regarding your rights and information about compensation for injuries.

The information you provide will only be used in accordance with our terms and conditions. By submitting this form, you certify that you agree to our terms and conditions and want us to contact you regarding your inquiry.

* denotes required fields


Title
First Name
Middle Initial
Last Name
Address
Address Cont.
City
State
Zip Code
Phone Number (day)
Phone Number (eve)
E-mail

If this inquiry is not for yourself, please tell us the name of the person.
Title
First Name
Middle Initial
Last Name
What is this person's relationship to you?
Injured's date of birth:	[None]
Have you or they taken Avandia?	Yes No
Dates of use? (mm/yyyy - mm/yyyy)
What city and state was Avandia prescribed in?
Have you/loved one suffered a heart attack?	Yes No
Date of heart attack?
Do you currently have an attorney assisting you with this matter?	Yes No

Please briefly describe your legal issues and needs.

* I agree that submitting this form does not create an attorney client relationship.

View All News »

U.S. FDA says Glaxo failed to report Avandia data

U.S. FDA says Glaxo failed to report Avandia data 2008 04 08 GlaxoSmithKline failed to report all of the required post approval data on its diabetes drug Avandia to U.S. regulators, the Food and Drug Administration said in a

New Avandia study reaffirms heart risk

Older patients who took Avandia had a higher risk of heart attacks, congestive heart failure and death than those on other diabetes pills, according to a study of nearly 160,000 Canadians out Wednesday.For four years, the study followed patients over age 65, who have the highest rate of type 2 diabetes but aren't well-represented in clinical trials, says lead author Lorraine Lipscombe, a Toronto endocrinologist and researcher at the Institute for Clinical Evaluative Science, funded by the Ontario government.

View All Successes »